Form 4 Savara Inc For: 24 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Savara Inc (SVRA)
Savara Inc stock price live, this page displays NASDAQ SVRA stock exchange data. View the SVRA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Savara Inc real time stock price chart below.
What Is the Savara Inc Stock Price Today?
The Savara Inc stock price today is 5.2800.
What Is the Stock Symbol for Savara Inc?
The stock symbol for Savara Inc is "SVRA."
What Stock Exchange Does Savara Inc Trade On?
Savara Inc is listed and trades on the NASDAQ stock exchange.
Is Savara Inc a Good Stock to Buy?
Determining whether Savara Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SVRA quote. (ISIN: US8051111016)
What Is the Savara Inc Stock Price Today?
The Savara Inc stock price today is 5.2800.
What Is the Stock Symbol for Savara Inc?
The stock symbol for Savara Inc is "SVRA."
What Stock Exchange Does Savara Inc Trade On?
Savara Inc is listed and trades on the NASDAQ stock exchange.
Is Savara Inc a Good Stock to Buy?
Determining whether Savara Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SVRA quote. (ISIN: US8051111016)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.1800
5.4000
52 wk Range
2.4300
7.0050
Earnings results expected in 7 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.18005.4000
52 wk Range
2.43007.0050
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SVRA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
10.9375
Upside
+107.15%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings downwards for the upcoming period
Form 8K Savara Inc For: 8 June- Investing.com
Form 4 Savara Inc For: 22 June- Investing.com
- Form 4 Savara Inc For: 24 July
- Investing.com
- Form 4 Savara Inc For: 22 June
- Investing.com
Form 144 Savara Inc For: 22 June- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 10.9375
(+107.15% Upside)
Savara Inc SWOT Analysis
Breakthrough Therapy | Savara's Molbreevi, a potential first-in-class treatment for aPAP, completes BLA submission with promising Phase 3 data and Breakthrough Therapy designation |
Market Opportunity | Explore the expanded addressable market for aPAP treatment, with over 7,000 potential patients in the U.S. and projected peak sales exceeding $1 billion |
Financial Outlook | Delve into Savara's financial strategy, including $173M cash reserves and a $200M debt agreement, supporting operations through potential 2026 product launch |
Analyst Projections | Analyst price targets range from $2 to $16 per share, with Wells Fargo and JMP Securities maintaining bullish outlooks of $7 and $9, respectively |
Earnings
Latest Release
May 12, 2026
EPS / Forecast
-0.15 / -0.12
Revenue / Forecast
-- / --
Compare SVRA to Peers and Sector
Metrics to compare | SVRA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSVRAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.3x | −1.3x | −0.3x | |
PEG Ratio | 0.80 | −0.02 | 0.00 | |
Price/Book | 7.6x | 1.6x | 2.6x | |
Price / LTM Sales | - | 57.9x | 2.9x | |
Upside (Analyst Target) | 94.1% | 194.1% | 56.7% | |
Fair Value Upside | Unlock | 3.8% | 10.2% | Unlock |
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company’s lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Savara (SVRA) Stock Price Today?
The Savara stock price today is 5.2800 USD.
What Stock Exchange Does Savara Trade On?
Savara is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Savara?
The stock symbol for Savara is "SVRA."
What Is the Savara Market Cap?
As of today, Savara market cap is 1.3400B USD.
What Is Savara's Earnings Per Share (TTM)?
The Savara EPS (TTM) is -0.5589.
When Is the Next Savara Earnings Date?
Savara will release its next earnings report on Aug 06, 2026.
From a Technical Analysis Perspective, Is SVRA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Savara Stock Split?
Savara has split 2 times.
How Many Employees Does Savara Have?
Savara has 70 employees.
What is the current trading status of Savara (SVRA)?
As of Jul 30, 2026, Savara (SVRA) is trading at a price of 5.2800 USD, with a previous close of 5.2800 USD. The stock has fluctuated within a day range of 5.1800 USD to 5.4000 USD, while its 52-week range spans from 2.4300 USD to 7.0050 USD.
What Is Savara (SVRA) Price Target According to Analysts?
The average 12-month price target for Savara is 10.9375 USD, with a high estimate of 16 USD and a low estimate of 9 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +107.15% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.